Latin America’s agricultural sector runs on glyphosate. Knowing who makes it can mean the difference between a smart sourcing decision and a costly mistake.

The region has become one of the world’s most competitive markets for Herbicide supply. A handful of major glyphosate manufacturers control most of the production, distribution, and innovation. Not all of them operate at the same scale, offer the same reliability, or serve the same markets.

Are you a distributor, agronomist, or procurement manager? This breakdown of the top five players gives you a clear, no-fluff picture of who’s shaping the industry right now.

Syngenta

Syngenta doesn’t just participate in the Latin American agrochemical market — it shapes it.

As one of the world’s largest agricultural science companies, Syngenta brings something most glyphosate manufacturers cannot match: global R&D power combined with deep regional roots. Its crop protection division generated $9.8 billion in sales through the first nine months of 2025, up 3% year-over-year. That growth came from volume, not price hikes. Real demand for Syngenta products is expanding — the numbers make that clear.

Financial Strength That Translates to Supply Reliability

Sourcing herbicides at scale? Your supplier‘s financial health becomes your concern too. A manufacturer under cash flow pressure cuts corners. They delay shipments. They renegotiate terms mid-contract.

Syngenta is not that manufacturer.

Through the first nine months of 2025, the Syngenta Group posted EBITDA of $3.4 billion — up 25% compared to the same period in 2024. Its EBITDA margin expanded from 12.9% to 16.5%. In Q3 2025 alone, EBITDA surged 28% year-over-year. These aren’t vanity metrics. They show a company with strong operational discipline. There’s enough margin buffer to keep investing forward, not scrambling to stay afloat.

Innovation Pipeline and Latin America Relevance

Here’s what sets Syngenta apart from generic glyphosate suppliers: the company cleared more than 1,200 product approvals in 2025 across its global portfolio. For Brazil, it launched three new TYMIRIUM-based products targeting nematode and fungal control — two critical concerns for soybean and sugarcane growers across the region.

Its biologicals segment is posting double-digit sales growth. That signals Syngenta is already building the product range that will define the next decade of crop protection. Glyphosate stays central to that range, but it sits within a broader, integrated agronomic offering — not as a standalone product.

What This Means for Buyers

For distributors and procurement teams in Latin America, Syngenta is a premium but low-risk sourcing partner. You pay for reliability, regulatory compliance, and technical support. In agricultural supply chains, those three things are worth every peso.

Bayer AG (CropScience)

Bayer’s Crop Science division posted €21.622 billion in full-year 2025 sales. That number matters. For glyphosate manufacturers in Latin America, it signals the kind of infrastructure, pipeline, and market reach that no smaller operation can match.

Raw revenue, though, doesn’t tell the full story.

Stable on Glyphosate, Aggressive on Innovation

Bayer’s glyphosate segment held steady in FY 2025. Price increases offset volume declines, keeping the segment at €2.6 billion. That’s not an accident. Bayer isn’t chasing volume at the cost of margin. It’s treating glyphosate as a mature cash engine — and pushing new investment into what’s coming next.

What’s coming next is significant:

• Preceon™ Smart Corn System — a new seed-trait platform built for yield improvement

• Vyconic™ soybeans — designed to tolerate five different Herbicide modes of action, including glyphosate-compatible combinations

• icafolin — a new-generation herbicide built to work alongside current weed control programs

Latin American buyers — especially those running soybean and corn operations in Brazil and Argentina — should pay attention here. The region is one of Bayer Crop Science’s key volume markets. Its corn seed and traits category grew +13% across global markets in FY 2025. Latin American demand drove a solid part of that growth.

The Numbers Behind the Reliability Question

Procurement teams ask a fair question: is this supplier stable enough to build a long-term contract around?

Bayer’s FY 2025 EBITDA margin for Crop Science came in at 19.4% — flat year-over-year. Its targets for 2029 include raising that margin into the mid-20s, adding >€3.5 billion in new innovation sales, and keeping free operating cash flow above €3 billion.

These aren’t projections on a slide deck. A five-year operational plan backs them up. That plan covers trimming the product portfolio, focusing R&D on high-value innovations, and tightening the global production network.

Yes, the restructuring cut ~13,500 positions across the Bayer Group. That’s a real number. It reflects the cost discipline Bayer is applying across its operations. Leaner doesn’t mean weaker. In Bayer’s case, it means a Crop Science division with sharper focus and clearer capital priorities.

What Buyers in Latin America Should Know

Bayer holds a strong position among glyphosate manufacturers in the region. Price leadership isn’t the reason. Control over seed genetics, herbicide chemistry, and regulatory infrastructure — all at once — is what sets it apart. For distributors and agronomists building multi-season supply relationships, that integrated position is hard to find elsewhere.

BASF SE

Sixty billion euros in annual sales. That’s the scale BASF operates at — and it shapes everything about how the company competes as one of the world’s largest glyphosate manufacturers.

In 2025, BASF posted €59,657 million in total sales, down from €61,444 million the year before. The drop wasn’t about demand. Volume grew +1.5%. What pulled the top line down were currency headwinds (-3.0%) and price softness (-1.7%) — external pressures, not operational failures. That distinction matters. You’re looking at a long-term supply partner, so the cause of a revenue dip tells you more than the number itself.

Profitability Under Pressure — and What It Reveals

EBITDA before special items came in at €6,554 million, with a margin of 11.0% (down from 11.8% in 2024). On the surface, that looks like compression. Look deeper and a different story emerges.

Net income improved — from €1,300 million in 2024 to €1,619 million in 2025. Free cash flow rose from €0.7 billion to €1.3 billion, close to double. ROCE climbed from 5.1% to 5.8%. These aren’t the metrics of a company in retreat. They’re the metrics of a company getting leaner while staying solvent.

BASF cut capital expenditure from €6.2 billion to €4.3 billion. That was a deliberate move to improve cash conversion — not a sign of reduced ambition.

What the 2026 Outlook Says to Buyers

BASF’s forward guidance is clear: EBITDA of €6.2–7.0 billion, free cash flow of €1.5–2.3 billion, and capex of €3.4 billion. The dividend holds at €2.25 per share — unchanged from 2024. The board isn’t signaling concern. It’s signaling confidence in cash generation.

Procurement teams evaluating glyphosate manufacturers in Latin America should pay attention to that stability. A company that keeps dividends steady through €937 million in restructuring charges and currency losses isn’t reacting. It’s following a plan.

BASF doesn’t lead with noise. It leads with chemistry, scale, and a balance sheet built to outlast market cycles.

UPL Ltd

A year ago, UPL was bleeding. Net loss of ₹12.0 billion in FY24. Debt sitting at ₹221.7 billion. Working capital stretched to 86 days. Those numbers pushed procurement managers to start looking elsewhere.

FY25 told a different story.

Revenue climbed to ₹466.4 billion — up 8% year-over-year. EBITDA surged 47% to ₹81.2 billion, with margins expanding 460 basis points to 17.4%. Net profit swung from a ₹12.0 billion loss to a ₹9.0 billion gain. That’s not a recovery. That’s a reset.

The Debt Story Is the Real Story

Glyphosate buyers in Latin America tend to overlook financial leverage as a supplier risk. UPL’s debt load was a real concern going into FY25.

Then the company cut it by ₹83.2 billion in a single year.

Net debt fell from ₹221.7 billion to ₹138.6 billion ($1.62 billion). Working capital days dropped from 86 to 53. Free cash flow drove the debt reduction — not asset sales, not share dilution. That matters. It shows operational discipline, not a company scrambling to survive.

Q4 FY25 backed that up. EBITDA jumped 68% year-over-year to ₹32.4 billion. Contribution margins hit 38.1% — up 870 basis points. Volume grew +11% in the quarter.

What This Means for Latin American Buyers

UPL operates at scale across emerging markets. Its roots are in agricultural environments that are price-sensitive, volume-driven, and weather-dependent — the same conditions that shape Latin America’s buying decisions.

TTM revenue of $5.49 billion USD places UPL in the top tier of global suppliers. That scale means the infrastructure is there to handle large, multi-season contracts. The turnaround numbers confirm the business is running well again.

Distributors comparing glyphosate manufacturers now have a clearer picture. UPL enters 2025 not as a company in decline — but as one that did the hard restructuring work and came out stronger.

Nufarm Ltd

Nufarm’s FY2025 numbers make for uncomfortable reading. Adjusted EBITDA dropped to A$131 million — down from A$189 million the previous year. S&P Global Ratings took notice. The agency downgraded Nufarm to ‘B+’, citing the EBITDA decline and its direct hit on the company’s adjusted leverage ratio.

That’s the honest picture. No softening it.

What the Downgrade Signals

A credit rating cut doesn’t rule out a supplier. But it does shift the conversation — for procurement managers building multi-season contracts and distributors managing payment terms and delivery reliability.

What S&P flagged wasn’t a short-term blip. It was a structural drop in EBITDA that tightened Nufarm’s financial room to move. If you’re evaluating glyphosate manufacturers across Latin America, that distinction matters. Here’s why:

• Compressed margins leave less room to absorb pressure

• A tighter balance sheet limits options fast

• Supply chain disruptions, input cost spikes, or currency swings all cut into working capital — and a stretched supplier feels that pain first

Where Nufarm Still Has Ground

Nufarm isn’t a global giant — and it doesn’t try to be. Its strength sits in specific regions and crop types where larger manufacturers don’t compete as hard. Australia, Europe, and parts of Latin America remain active markets for its crop protection portfolio.

The company released full-year FY2025 results on 19 November 2025. An investor briefing and webcast are available through the Nufarm Investor Centre.

The results are public. The rating is lower. For buyers, the move is clear: review the numbers, weigh the contract terms with care, and benchmark Nufarm against better-capitalized alternatives before committing at scale.

The glyphosate market in Latin America has no shortage of serious players — and now you know who’s leading it.

Bayer brings deep agricultural roots. Nufarm offers strong regional agility. Each of these glyphosate manufacturers brings something different to the table. The real differentiator isn’t just who makes the product. It’s who understands your crop cycles, your soil conditions, and your local regulatory environment well enough to stand behind it.

So what’s your next move?

Start by shortlisting two or three manufacturers. Base your choices on your country’s import regulations and distribution infrastructure. Then request technical datasheets. Compare formulation strengths. Don’t skip the conversation about after-sales support — it matters more than most buyers expect.

• Check registration status in your country before committing

• Compare active ingredient concentration across brands

• Ask about local distributor networks and delivery timelines

• Get clarity on technical support after the sale

The right glyphosate partner does more than ship a herbicide. They protect your yield and your margins.

Pick the one that fits your operation — not just your budget.